Gary H. Gibbons, M.D., is Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH), where he oversees the third largest institute, with an annual budget of approximately $3 billion and nearly 1,000 employees.
Since being named Director of the NHLBI, Dr. Gibbons has enhanced the investment in fundamental discovery science by steadily increasing the payline and number of awards for early and established investigators. He also provides leadership to advance several key NIH initiatives such as precision medicine and biomedical research workforce diversity.
Dr. Gibbons has made many scientific contributions and received several patents for innovations in the fields of vascular biology, genomic medicine, and the pathogenesis of vascular diseases. His research focuses on investigating the relationships between clinical phenotypes, behavior, molecular interactions, and social determinants on gene expression and their contribution to cardiovascular disease.
Prior to his current position, Dr. Gibbons was a member of the faculty at Stanford University from 1990-1996 and Harvard Medical School from 1996-1999. He joined Morehouse School of Medicine in 1999, where he served as the founding director of the Cardiovascular Research Institute, Chair of the Department of Physiology, and Professor of Physiology and Medicine.
Dr. Gibbons is an elected member of the Institute of Medicine of the National Academies of Sciences, a Robert Wood Johnson Foundation Minority Faculty Development Awardee, a Pew Foundation Biomedical Scholar, and an Established Investigator of the American Heart Association.